Industry: Service & Software
Published Date: 2025-12-12
Pages: 127 Pages
Report ld: 3454569
Request Sample
Customized Report
Genome Sequencing Service Market Size(US$)

CAGR 2025-2031
18.0%
Market Size,2031
USD 75,790
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Genome Sequencing Service was valued at US$ 23729 million in the year 2024 and is projected to reach a revised size of US$ 75790 million by 2031, growing at a CAGR of 18.0% during the forecast period.
Genome Sequencing Service refers to a comprehensive biotechnology service provided by professional organizations, leveraging high-throughput sequencing platforms, bioinformatics analysis technologies, and standardized experimental procedures. This service offers integrated genomic DNA extraction, sequencing, data interpretation, and analysis to clients such as research institutions, medical institutions, and enterprises. Its core principle is to read the base sequences of the entire genome or specific gene fragments of an organism or species using sequencing equipment, and then combine this with bioinformatics tools to analyze the genetic information contained within the sequences. Ultimately, this provides precise genetic data support for basic scientific research, disease diagnosis, agricultural breeding, and other fields.
Clinical diagnosis has long been the core application of this service, and its use continues to deepen. In the field of oncology, sequencing-based targeted therapy has become the mainstream approach, and technologies such as liquid biopsy are driving the service to extend from treatment guidance to early screening. In the field of genetic disease screening, non-invasive prenatal testing has become widespread, and the advancement of the Newborn Genome Project has further expanded the service coverage. Furthermore, sequencing services are increasingly being used for medication guidance in chronic diseases, reducing adverse drug reactions and achieving precision medicine.
Beyond the medical field, sequencing services are rapidly penetrating into agriculture, microbiology, and other fields. In agriculture, sequencing helps uncover genes related to crop stress resistance and high yield, aiding in the breeding of superior varieties and ensuring food security. In the field of microbiology, metagenomic sequencing eliminates the need for strain isolation and culture, enabling the identification of pathogenic microorganisms and analysis of gut microbiota diversity, and is widely used in public health and disease prevention as well as biomedical research and development. Simultaneously, its applications in forensic identification and endangered species protection are also being explored.
This report aims to provide a comprehensive presentation of the global market for Genome Sequencing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genome Sequencing Service.
The Genome Sequencing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genome Sequencing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, by Scene and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genome Sequencing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Scene etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genome Sequencing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genome Sequencing Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Whole-Genome Sequencing
1.2.3 Whole exome Sequencing
1.2.4 Others
1.3 Market by Scene
1.3.1 Global Genome Sequencing Service Market Size Growth Rate by Scene: 2020 VS 2024 VS 2031
1.3.2 Scientific Research
1.3.3 Clinical
1.3.4 Agriculture
1.3.5 Others
1.4 Market by Genome
1.4.1 Global Genome Sequencing Service Market Size Growth Rate by Genome: 2020 VS 2024 VS 2031
1.4.2 DNA
1.4.3 RNA
1.5 Market by Application
1.5.1 Global Genome Sequencing Service Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Humanity
1.5.3 Plant
1.5.4 Animal
1.5.5 Microorganism
1.5.6 Virus
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Genome Sequencing Service Market Perspective (2020-2031)
2.2 Global Genome Sequencing Service Growth Trends by Region
2.2.1 Global Genome Sequencing Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Genome Sequencing Service Historic Market Size by Region (2020-2025)
2.2.3 Genome Sequencing Service Forecasted Market Size by Region (2026-2031)
2.3 Genome Sequencing Service Market Dynamics
2.3.1 Genome Sequencing Service Industry Trends
2.3.2 Genome Sequencing Service Market Drivers
2.3.3 Genome Sequencing Service Market Challenges
2.3.4 Genome Sequencing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genome Sequencing Service Players by Revenue
3.1.1 Global Top Genome Sequencing Service Players by Revenue (2020-2025)
3.1.2 Global Genome Sequencing Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Genome Sequencing Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Genome Sequencing Service Revenue
3.4 Global Genome Sequencing Service Market Concentration Ratio
3.4.1 Global Genome Sequencing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome Sequencing Service Revenue in 2024
3.5 Global Key Players of Genome Sequencing Service Head office and Area Served
3.6 Global Key Players of Genome Sequencing Service, Product and Application
3.7 Global Key Players of Genome Sequencing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genome Sequencing Service Breakdown Data by Type
4.1 Global Genome Sequencing Service Historic Market Size by Type (2020-2025)
4.2 Global Genome Sequencing Service Forecasted Market Size by Type (2026-2031)
5 Genome Sequencing Service Breakdown Data by Application
5.1 Global Genome Sequencing Service Historic Market Size by Application (2020-2025)
5.2 Global Genome Sequencing Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Genome Sequencing Service Market Size (2020-2031)
6.2 North America Genome Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Genome Sequencing Service Market Size by Country (2020-2025)
6.4 North America Genome Sequencing Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genome Sequencing Service Market Size (2020-2031)
7.2 Europe Genome Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Genome Sequencing Service Market Size by Country (2020-2025)
7.4 Europe Genome Sequencing Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Genome Sequencing Service Market Size (2020-2031)
8.2 Asia-Pacific Genome Sequencing Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Genome Sequencing Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Genome Sequencing Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Genome Sequencing Service Market Size (2020-2031)
9.2 Latin America Genome Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Genome Sequencing Service Market Size by Country (2020-2025)
9.4 Latin America Genome Sequencing Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genome Sequencing Service Market Size (2020-2031)
10.2 Middle East & Africa Genome Sequencing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Genome Sequencing Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Genome Sequencing Service Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Genome Sequencing Service Introduction
11.1.4 Illumina Revenue in Genome Sequencing Service Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Genome Sequencing Service Introduction
11.2.4 Thermo Fisher Scientific Revenue in Genome Sequencing Service Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 BGI Genomics
11.3.1 BGI Genomics Company Details
11.3.2 BGI Genomics Business Overview
11.3.3 BGI Genomics Genome Sequencing Service Introduction
11.3.4 BGI Genomics Revenue in Genome Sequencing Service Business (2020-2025)
11.3.5 BGI Genomics Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Genome Sequencing Service Introduction
11.4.4 Agilent Technologies Revenue in Genome Sequencing Service Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 CD Genomics
11.5.1 CD Genomics Company Details
11.5.2 CD Genomics Business Overview
11.5.3 CD Genomics Genome Sequencing Service Introduction
11.5.4 CD Genomics Revenue in Genome Sequencing Service Business (2020-2025)
11.5.5 CD Genomics Recent Development
11.6 Azenta Life Sciences
11.6.1 Azenta Life Sciences Company Details
11.6.2 Azenta Life Sciences Business Overview
11.6.3 Azenta Life Sciences Genome Sequencing Service Introduction
11.6.4 Azenta Life Sciences Revenue in Genome Sequencing Service Business (2020-2025)
11.6.5 Azenta Life Sciences Recent Development
11.7 Broad Clinical Labs
11.7.1 Broad Clinical Labs Company Details
11.7.2 Broad Clinical Labs Business Overview
11.7.3 Broad Clinical Labs Genome Sequencing Service Introduction
11.7.4 Broad Clinical Labs Revenue in Genome Sequencing Service Business (2020-2025)
11.7.5 Broad Clinical Labs Recent Development
11.8 Macrogen
11.8.1 Macrogen Company Details
11.8.2 Macrogen Business Overview
11.8.3 Macrogen Genome Sequencing Service Introduction
11.8.4 Macrogen Revenue in Genome Sequencing Service Business (2020-2025)
11.8.5 Macrogen Recent Development
11.9 GE Healthcare Life Sciences
11.9.1 GE Healthcare Life Sciences Company Details
11.9.2 GE Healthcare Life Sciences Business Overview
11.9.3 GE Healthcare Life Sciences Genome Sequencing Service Introduction
11.9.4 GE Healthcare Life Sciences Revenue in Genome Sequencing Service Business (2020-2025)
11.9.5 GE Healthcare Life Sciences Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Genome Sequencing Service Introduction
11.10.4 Johnson & Johnson Revenue in Genome Sequencing Service Business (2020-2025)
11.10.5 Johnson & Johnson Recent Development
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Details
11.11.2 Abbott Laboratories Business Overview
11.11.3 Abbott Laboratories Genome Sequencing Service Introduction
11.11.4 Abbott Laboratories Revenue in Genome Sequencing Service Business (2020-2025)
11.11.5 Abbott Laboratories Recent Development
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Genome Sequencing Service Introduction
11.12.4 Bayer Revenue in Genome Sequencing Service Business (2020-2025)
11.12.5 Bayer Recent Development
11.13 Microchip Biotechnologies
11.13.1 Microchip Biotechnologies Company Details
11.13.2 Microchip Biotechnologies Business Overview
11.13.3 Microchip Biotechnologies Genome Sequencing Service Introduction
11.13.4 Microchip Biotechnologies Revenue in Genome Sequencing Service Business (2020-2025)
11.13.5 Microchip Biotechnologies Recent Development
11.14 GeneDx
11.14.1 GeneDx Company Details
11.14.2 GeneDx Business Overview
11.14.3 GeneDx Genome Sequencing Service Introduction
11.14.4 GeneDx Revenue in Genome Sequencing Service Business (2020-2025)
11.14.5 GeneDx Recent Development
11.15 Commonwealth Biotechnologies
11.15.1 Commonwealth Biotechnologies Company Details
11.15.2 Commonwealth Biotechnologies Business Overview
11.15.3 Commonwealth Biotechnologies Genome Sequencing Service Introduction
11.15.4 Commonwealth Biotechnologies Revenue in Genome Sequencing Service Business (2020-2025)
11.15.5 Commonwealth Biotechnologies Recent Development
11.16 ZS Genetics
11.16.1 ZS Genetics Company Details
11.16.2 ZS Genetics Business Overview
11.16.3 ZS Genetics Genome Sequencing Service Introduction
11.16.4 ZS Genetics Revenue in Genome Sequencing Service Business (2020-2025)
11.16.5 ZS Genetics Recent Development
11.17 Pacific Biosciences
11.17.1 Pacific Biosciences Company Details
11.17.2 Pacific Biosciences Business Overview
11.17.3 Pacific Biosciences Genome Sequencing Service Introduction
11.17.4 Pacific Biosciences Revenue in Genome Sequencing Service Business (2020-2025)
11.17.5 Pacific Biosciences Recent Development
11.18 Novogene
11.18.1 Novogene Company Details
11.18.2 Novogene Business Overview
11.18.3 Novogene Genome Sequencing Service Introduction
11.18.4 Novogene Revenue in Genome Sequencing Service Business (2020-2025)
11.18.5 Novogene Recent Development
11.19 Eurofins Genomics
11.19.1 Eurofins Genomics Company Details
11.19.2 Eurofins Genomics Business Overview
11.19.3 Eurofins Genomics Genome Sequencing Service Introduction
11.19.4 Eurofins Genomics Revenue in Genome Sequencing Service Business (2020-2025)
11.19.5 Eurofins Genomics Recent Development
11.20 Psomagen
11.20.1 Psomagen Company Details
11.20.2 Psomagen Business Overview
11.20.3 Psomagen Genome Sequencing Service Introduction
11.20.4 Psomagen Revenue in Genome Sequencing Service Business (2020-2025)
11.20.5 Psomagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Genome Sequencing Service market size was US$ 28130 million in 2025 and is forecast to reach a readjusted size of US$ 88040 million by 2032 with a CAGR of 18.0% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 105
USD 4250.00
(Single User License)
The global market for Genome Sequencing Service was estimated to be worth US$ 28130 million in 2025 and is projected to reach US$ 88040 million, growing at a CAGR of 18.0% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 139
USD 3950.00
(Single User License)
The global Genome Sequencing Service market was valued at US$ 28130 million in 2025 and is anticipated to reach US$ 88040 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 130
USD 2900.00
(Single User License)
The global market for Genome Sequencing Service was estimated to be worth US$ 23729 million in 2024 and is forecast to a readjusted size of US$ 75790 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
Published Date: 2025-12-12
Pages: 139
USD 3950.00
(Single User License)
The global Genome Sequencing Service market size was US$ 23729 million in 2024 and is forecast to a readjusted size of US$ 75790 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
Published Date: 2025-12-12
Pages: 103
USD 4250.00
(Single User License)
The global Genome Sequencing Service market is projected to grow from US$ 23729 million in 2024 to US$ 75790 million by 2031, at a CAGR of 18.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-12-12
Pages: 160
USD 4900.00
(Single User License)
The global market for Genome Sequencing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 134
USD 3950.00
(Single User License)
The global market for Genome Sequencing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 169
USD 3950.00
(Single User License)
The global Genome Sequencing Service market size was US$ 28130 million in 2025 and is forecast to reach a readjusted size of US$ 88040 million by 2032 with a CAGR of 18.0% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 105
The global market for Genome Sequencing Service was estimated to be worth US$ 28130 million in 2025 and is projected to reach US$ 88040 million, growing at a CAGR of 18.0% from 2026 to 2032.
Published: 2026-03-06
Pages: 139
The global Genome Sequencing Service market was valued at US$ 28130 million in 2025 and is anticipated to reach US$ 88040 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Published: 2026-03-06
Pages: 130
The global market for Genome Sequencing Service was estimated to be worth US$ 23729 million in 2024 and is forecast to a readjusted size of US$ 75790 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 139
The global Genome Sequencing Service market size was US$ 23729 million in 2024 and is forecast to a readjusted size of US$ 75790 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 103
The global Genome Sequencing Service market is projected to grow from US$ 23729 million in 2024 to US$ 75790 million by 2031, at a CAGR of 18.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-12-12
Pages: 160
The global market for Genome Sequencing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 134
The global market for Genome Sequencing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 169
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now